drugset / Trial / NCT02836470

A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection

NCT02836470

Phase 2 Completed 112 enrolled Palisade Bio
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to establish preliminary evidence of the efficacy, safety, and tolerability of LB1148 for the treatment of post-operative ileus and intra-abdominal adhesions in subjects undergoing elective bowel resection.

Timeline

Start
2019-10-01
Primary completion
2023-09-06
Completion
2023-09-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 700 ml Oral

Indications